Yarrow Bioscience, Inc. business relationships
Companies named in Yarrow Bioscience, Inc.’s 10-K filed 2026-02-27, and public companies whose annual reports name Yarrow Bioscience, Inc.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 4.0 / 10
- AI naming
- <1 / 100 Top 19% in its category
- Agent readiness
- 30 / 100
- AI adoption
- 0 / 100
Named in Yarrow Bioscience, Inc.’s annual report 1
“We previously licensed the rights to Finacea to LEO Pharma A/S ("LEO Pharma").” SEC filing
Companies whose annual reports name Yarrow Bioscience, Inc. 1
“As of January 2026, recruitment ongoing in China only and ex-China rights were licensed to Yarrow Bioscience in December 2025.” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.